Malignant tumors
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patient Inclusion Criteria: (1) Voluntary participation in this study; (2) Pathological diagnosis confirmed as malignant tumor; (3) Normal language communication skills, able to cooperate with the completion of assessments and surveys; (4) The patient will receive chemotherapy during this hospitalization (chemotherapy combined with immunotherapy, anti-angiogenic therapy, targeted therapy, and radiotherapy is allowed); (5) The patient had no severe fatigue. Caregiver Inclusion Criteria: (1) Family caregivers of patients with malignant tumors; (2) The caregiver will not change during the patient's hospitalization; (3) be able to complete this questionnaire independently or under the guidance of the investigator; (4) Those who are aware of the patient's condition and sign the consent form; (5) Family caregivers had no anxiety or depression.
Exclusion criteria
Exclusion criteria: (1) Those who withdraw or refuse to participate in this study during the investigation; (2) Those with cognitive or mental disorders; (3) There is a known conflict between the caregiver and the patient; (4) Professional escort; (5) The caregiver has serious diseases (including but not limited to: malignant tumors, various diseases with obvious symptoms).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To clarify the incidence of chemotherapy-induced bone marrow suppression in patients with malignant tumors and its impact on patient fatigue; | — |
Secondary
| Measure | Time frame |
|---|---|
| The impact of psychological status and sleep quality of family caregivers on patients with malignant tumors and chemotherapy combined with bone marrow suppression and analysis of related; | — |
Countries
China
Contacts
West China Hospital of Sichuan University